GlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billionU.K.-based GlaxoSmithKline Plc and Germany-based Merck KGaA are entering a partnership to develop and commercialize a therapy for patients with advanced non-small cell lung cancer in a deal worth up to $4.23 billion, the companies announced Tuesday.
Baca lebih lajut »
Stocks making the biggest moves premarket: Viacom, Centene, Merck, Alphabet & moreSome of the names on the move ahead of the open.
Baca lebih lajut »
Merck named the best pharma stock by Bank of AmericaBank of America named Merck its top pick among the many U.S. pharmaceutical stocks thanks to the growing success of its key cancer drug.
Baca lebih lajut »
Stocks making the biggest moves premarket: Amazon, Merck, Cigna, Honeywell & moreSome of the names on the move ahead of the open.
Baca lebih lajut »
Stocks making the biggest moves midday: Amazon, Merck, Exxon Mobil & moreThese are the stocks posting the largest moves midday Friday.
Baca lebih lajut »
GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billionU.K.-based GlaxoSmithKline Plc and Germany-based Merck KGaA are entering a partnership to develop and commercialize a therapy for patients with advanced non-small cell lung cancer in a deal worth up to $4.23 billion, the companies announced Tuesday.
Baca lebih lajut »